Imatinib and nilotinib reverse multidrug resistance in cancer cells by inhibiting the efflux activity of the MRP7 (ABCC10) Article (Faculty180)

cited authors

  • Shen, Tong; Kuang, Ye-Hong; Ashby Jr, , Charles; Lei, Y u; Chen, Angel; Zhou, Ying; Chen, Xiang; Tiwari, Amit K; Hopper-Borge, Elizabeth; Ouyang, Jiangyong; others

publication date

  • 2009

published in

start page

  • e7520

volume

  • 4